Medical Marijuana Expands Executive Team with New Talent


Ryan Allway

April 5th, 2016

News, Top News


[stockchart symbol=MJNA]

Medical Marijuana, Inc. [stockquote symbol=MJNA], a premier hemp industry innovator, recently announced the appointment of Blake N. Schroeder, Esq., as Vice President of Operations at Medical Marijuana, Inc. and CEO of Kannaway LLC, a portfolio company. With extensive business experience spanning multiple industries, Mr. Schroeder will be responsible for rebranding the company as it expands into Europe and around the world.

“We are thrilled to make the announcement of Blake N. Schroeder, Esq., joining our executive leadership team,” said Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Even in turbulent economic times, Blake has consistently proven his capability of increasing revenue and growing multi-national organizations. His background with multinational marketing companies in the health and nutrition field is an extremely valuable asset. We welcome him to the MJNA team.”

“After a few visits with the executive management team at Medical Marijuana, Inc., I was crystal clear about the vision and passion behind the company, as well as the opportunity to lead in an emerging space,” said Mr. Schroeder. “The choice to join the MJNA team was simple. My goal is to consistently deliver dramatic performance results, pioneer new business strategies and improve operations. Being a natural communicator has allowed me to implement strong training and leadership structure within companies to generate positive results. I’m looking forward to implementing these proven methods and expanding Medical Marijuana, Inc.’s brand presence worldwide.”

The news comes shortly after Kannalife Sciences received a quota allotment from the Drug Enforcement Administration to import pharmaceutical grade cannabidiol into the U.S. The company plans to use the CBD in a feasibility study currently being conducted by Catalent Pharma Solutions. KannaLife Science is targeting the neurodegenerative diseases hepatic encephalopathy and chronic traumatic encephalopathy with its compounds.

Kannalife Sciences hold two licenses from the NIH for patents covering cannabinoids as antioxidants and neuroprotectants that it plans to leverage to develop proprietary therapeutics targeting CTE and HE.

Medical Marijuana’s goal is to leverage its team of professionals to source, evaluate, and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. For more information, visit the company’s website at www.medicalmarijuanainc.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading